1x Radiopharmaceuticals Market Size, Share & Trends Analysis Report by Type (Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters) by Application (Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications) by Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures, Source) by Source (Nuclear Reactors, Cyclotrons) by End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2017 - 2022) & Forecast (2023 - 2030)